Neogen Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6404911066
USD
9.05
-0.2 (-2.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Feb'26
Nov'25
Aug'25
May'25
Feb'25
Nov'24
Aug'24
Net Sales
211.20
224.69
209.19
225.46
220.98
231.26
216.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
211.20
224.69
209.19
225.46
220.98
231.26
216.96
Raw Material Cost
135.00
140.91
137.22
156.12
134.01
141.53
130.53
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.90
14.85
16.44
17.13
17.74
18.14
18.61
Selling and Distribution Expenses
75.30
78.47
82.94
70.90
70.50
67.56
72.58
Other Expenses
-1.01
-1.03
-1.13
-1.08
-1.33
-1.30
-1.34
Total Expenditure (Excl Depreciation)
214.10
223.94
225.28
233.33
208.99
214.19
208.30
Operating Profit (PBDIT) excl Other Income
-2.9
0.7000000000000001
-16.1
-7.9
12
17.1
8.7
Other Income
-3.10
0.12
76.21
-3.03
2.54
-1.30
-0.80
Operating Profit (PBDIT)
22.90
29.79
89.17
19.36
43.90
45.82
37.66
Interest
13.90
14.85
16.44
17.13
17.74
18.14
18.61
Exceptional Items
-0.40
-6.38
0.13
-603.17
-6.52
-474.20
-4.86
Gross Profit (PBDT)
76.20
83.78
71.97
69.34
86.97
89.73
86.44
Depreciation
28.90
28.93
29.05
30.26
29.37
30.05
29.80
Profit Before Tax
-20.30
-20.36
43.81
-631.20
-9.73
-476.57
-15.61
Tax
-3.30
-4.44
7.47
-19.01
1.23
-20.29
-3.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-17.00
-15.92
36.34
-612.20
-10.96
-456.28
-12.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-17.00
-15.92
36.34
-612.20
-10.96
-456.28
-12.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-17.00
-15.92
36.34
-612.20
-10.96
-456.28
-12.61
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.16
0.16
0.16
0.16
0.16
0.16
0.16
Reserves
2,102.40
2,104.49
2,118.65
2,071.25
2,660.35
2,669.07
3,135.19
Earnings per share (EPS)
-0.08
-0.07
0.17
-2.82
-0.05
-2.1
-0.06
Diluted Earnings per share
-0.08
-0.07
0.17
-2.82
-0.05
-2.1
-0.06
Operating Profit Margin (Excl OI)
-1.37%
0.33%
-7.69%
-3.49%
5.42%
7.38%
3.99%
Gross Profit Margin
4.07%
3.81%
34.83%
-266.54%
8.89%
-193.08%
6.54%
PAT Margin
-8.05%
-7.09%
17.37%
-271.53%
-4.96%
-197.3%
-5.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Feb 2026 is -4.43% vs -3.41% in Feb 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Feb 2026 is -54.55% vs -450.00% in Feb 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Feb 2026 is -37.20% vs 0.24% in Feb 2025

stock-summary

Interest

YoY Growth in quarter ended Feb 2026 is -21.47% vs -6.35% in Feb 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Feb 2026 has fallen from Feb 2025

Compare Quarterly Results Of Neogen Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
211.20
759.85
-548.65
-72.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
211.20
759.85
-548.65
-72.21%
Raw Material Cost
135.00
262.00
-127.00
-48.47%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.90
0.00
13.90
Selling and Distribution Expenses
75.30
297.77
-222.47
-74.71%
Other Expenses
-1.01
3.65
-4.66
-127.67%
Total Expenditure (Excl Depreciation)
214.10
596.28
-382.18
-64.09%
Operating Profit (PBDIT) excl Other Income
-2.90
163.57
-166.47
-101.77%
Other Income
-3.10
6.69
-9.79
-146.34%
Operating Profit (PBDIT)
22.90
240.11
-217.21
-90.46%
Interest
13.90
0.00
13.90
Exceptional Items
-0.40
-13.18
12.78
96.97%
Gross Profit (PBDT)
76.20
497.85
-421.65
-84.69%
Depreciation
28.90
69.86
-40.96
-58.63%
Profit Before Tax
-20.30
157.07
-177.37
-112.92%
Tax
-3.30
32.77
-36.07
-110.07%
Provisions and contingencies
0
0
0.00
Profit After Tax
-17.00
124.30
-141.30
-113.68%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-17.00
124.30
-141.30
-113.68%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-17.00
124.30
-141.30
-113.68%
Equity Capital
0
0
0.00
Face Value
0.16
0.00
0.00
Reserves
2,102.40
4,732.31
-2,629.91
-55.57%
Earnings per share (EPS)
-0.08
0.90
-0.98
-108.89%
Diluted Earnings per share
-0.08
0.90
-0.98
-108.89%
Operating Profit Margin (Excl OI)
-1.37%
21.53%
0.00
-22.90%
Gross Profit Margin
4.07%
29.86%
0.00
-25.79%
PAT Margin
-8.05%
16.36%
0.00
-24.41%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 21.12 Million
in Feb 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2026 is -6.01% vs 7.41% in Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 is -4.43% vs -3.41% in Feb 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -1.70 Million
in Feb 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2026 is -6.92% vs -143.80% in Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 is -54.55% vs -450.00% in Feb 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.60 Million
in Feb 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2026 is -12.46% vs 128.46% in Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 is -37.20% vs 0.24% in Feb 2025

Quarterly - Interest
Interest 1.39 Million
in Feb 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Feb 2026 is -6.08% vs -9.76% in Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 is -21.47% vs -6.35% in Feb 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -1.37%
in Feb 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Feb 2026 has fallen from Nov 2025

stock-summary

YoY Growth in quarter ended Feb 2026 has fallen from Feb 2025